United States · FDA National Drug Code directory
Lamisil AT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84485-3605_21f1bf77-4338-4b75-b513-80a0d98a722a
- Product NDC
- 84485-3605
- Form
- SPRAY
- Composition / generic term
- terbinafine hydrochloride
- Labeler
- Karo Healthcare Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20251210
- Source listing expiry
- 20261231
Source-listed ingredients
- TERBINAFINE HYDROCHLORIDE — 1 g/100g
These values do not establish equivalence or a dose recommendation.
Packages
- 120 g in 1 CAN (84485-3605-4) · 84485-3605-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →